MIRUMIR statistics

Tool stats & trends

Looking to identify usage trends or leading experts?


MIRUMIR specifications


Unique identifier OMICS_12531
Interface Web user interface
Restrictions to use None
Computer skills Basic
Version 1.0
Stability Stable
Maintained Yes


  • person_outline Alexey V. Antonov

Publications for MIRUMIR

MIRUMIR citations


RNA Biomarkers: Frontier of Precision Medicine for Cancer

Noncoding RNA
PMCID: 5832009
PMID: 29657281
DOI: 10.3390/ncrna3010009

[…] ition system to curate a dataset of biomarkers with minimized false positive ratio [].Some other biomarker databases are more comprehensive than the above disease-centered databases (). For instance, MIRUMIR includes publicly available miRNA datasets annotated with patients’ survival information. It can be used to predict whether a given miRNA is a potential robust biomarker for survival of cancer […]


Circulating miR 200c and miR 141 and outcomes in patients with breast cancer

BMC Cancer
PMCID: 4405843
PMID: 25885099
DOI: 10.1186/s12885-015-1238-5
call_split See protocol

[…] ously published BC cohorts [,] were retrieved. Selected microRNAs, miR-200c and miR-141 were analysed further to assess whether they were associated with clinic and pathologic factors.The online tool MIRUMIR [] was used to estimate the power of miR-200c and miR-141 tumour expression to serve as potential biomarkers to predict survival of BC patients. MIRUMIR performs survival analyses across sever […]


p53 shapes genome wide and cell type specific changes in microRNA expression during the human DNA damage response

PMCID: 4601526
PMID: 25486198
DOI: 10.4161/15384101.2015.942209

[…] ce genome instability. Further studies to address this hypothesis are warranted.We were able to analyze if the DDR miRNA expression levels in tumor samples predict clinical outcomes in patients using MIRUMIR, a webserver that performs survival analyzes across several available data sets. Around half of the DDR miRNAs exhibited a significant association between their expression levels and patient s […]


Looking to check out a full list of citations?

MIRUMIR institution(s)
Medical Research Council Toxicology Unit, Leicester University, Leicester, UK; Department of Experimental Medicine and Surgery, University of Rome, Rome, Italy; Saint-Petersburg State Institute of Technology, Saint-Petersburg, Russia; Department of Biochemistry, University of Leicester, Leicester, UK; Institute of Cytology, Saint-Petersburg, Russia; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
MIRUMIR funding source(s)
This work was supported by the UK Medical Research Council (MRC) and funding from RFBS (10-04-01234), MCB RAS, Russian Federal grants 16.740.11.036 and 11.G34.31.0069.

MIRUMIR reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review MIRUMIR